Skip to main content
OpenTrials

Clinical trial condition

Angioimmunoblastic T-cell Lymphoma

Explore clinical trials studying Angioimmunoblastic T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

69 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Angioimmunoblastic T-cell Lymphoma trial results

Completed

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

NCT01466881

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
View all 161 locations
View Trial Details
Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma

NCT00901147

Conditions
Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative), Angioimmunoblastic T-cell Lymphoma, Enteropathy- Type T-cell Lymphoma, +20 more
Locations
  • Hospital Universiti Kebangsaan Malaysia ( HUKM ) Kuala Lumpur, Malaysia
  • Subang Jaya Medical Centre Subang Jaya, Selangor, Malaysia
  • National Cancer Center Singapore
  • Singapore General Hospital Singapore
View Trial Details

Related conditions